These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 21256508

  • 1. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
    Yu CH, Song GS, Yhee JY, Kim JH, Im KS, Nho WG, Lee JH, Sur JH.
    J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
    [Abstract] [Full Text] [Related]

  • 2. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J, Jellinger KA.
    Clin Neuropathol; 2006 Jul; 25(6):265-71. PubMed ID: 17140156
    [Abstract] [Full Text] [Related]

  • 3. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT, Trojanowski JQ, Lee VM.
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S.
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [Abstract] [Full Text] [Related]

  • 10. Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment.
    Smolek T, Madari A, Farbakova J, Kandrac O, Jadhav S, Cente M, Brezovakova V, Novak M, Zilka N.
    J Comp Neurol; 2016 Mar 01; 524(4):874-95. PubMed ID: 26239295
    [Abstract] [Full Text] [Related]

  • 11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 01; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 12. The cholinergic system in aging and neuronal degeneration.
    Schliebs R, Arendt T.
    Behav Brain Res; 2011 Aug 10; 221(2):555-63. PubMed ID: 21145918
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition.
    Oikawa N, Kimura N, Yanagisawa K.
    Brain Res; 2010 Feb 22; 1315():137-49. PubMed ID: 20004650
    [Abstract] [Full Text] [Related]

  • 15. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.
    Maeda S, Sahara N, Saito Y, Murayama S, Ikai A, Takashima A.
    Neurosci Res; 2006 Mar 22; 54(3):197-201. PubMed ID: 16406150
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.
    J Alzheimers Dis; 2010 Mar 22; 22(4):1363-73. PubMed ID: 20930272
    [Abstract] [Full Text] [Related]

  • 18. [Significance of tau in the development of Alzheimer's disease].
    Takashima A.
    Brain Nerve; 2010 Jul 22; 62(7):701-8. PubMed ID: 20675874
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE.
    Exp Neurol; 1994 Jul 22; 128(1):13-26. PubMed ID: 8070517
    [Abstract] [Full Text] [Related]

  • 20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY.
    Brain Res; 2005 Jan 07; 1031(1):101-8. PubMed ID: 15621017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.